Rhumbline Advisers Wave Life Sciences Ltd. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Rhumbline Advisers holds 125,834 shares of WVE stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,834

Previous 121,742 3.36%

Holding current value

$1.79 Million

Previous $751,000 16.51%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$4.38 - $6.48 $17,922 - $26,516	4,092 Added 3.36%	125,834 $627,000
Q1 2024 May 09, 2024	BUY	$3.54 - $6.84 $25,300 - $48,885	7,147 Added 6.24%	121,742 $751,000
Q4 2023 Feb 08, 2024	BUY	$4.16 - $6.87 $12,829 - $21,187	3,084 Added 2.77%	114,595 $578,000
Q3 2023 Nov 09, 2023	BUY	$3.56 - $5.75 $21,452 - $34,649	6,026 Added 5.71%	111,511 $641,000
Q2 2023 Aug 08, 2023	BUY	$3.51 - $4.69 $370,252 - $494,724	105,485 New	105,485 $383,000
Q2 2022 Aug 11, 2022	SELL	$1.23 - $3.25 $49,506 - $130,809	-40,249 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.0 - $3.28 $5,132 - $8,416	2,566 Added 6.81%	40,249 $80,000
Q4 2021 Feb 10, 2022	BUY	$3.14 - $5.15 $1,987 - $3,259	633 Added 1.71%	37,683 $118,000
Q3 2021 Nov 12, 2021	BUY	$4.89 - $7.12 $13,056 - $19,010	2,670 Added 7.77%	37,050 $182,000
Q2 2021 Aug 05, 2021	BUY	$5.65 - $7.47 $21,837 - $28,871	3,865 Added 12.67%	34,380 $229,000
Q1 2021 May 06, 2021	SELL	$5.61 - $12.01 $2,047 - $4,383	-365 Reduced 1.18%	30,515 $171,000
Q4 2020 Feb 10, 2021	BUY	$6.99 - $9.26 $36,033 - $47,735	5,155 Added 20.04%	30,880 $243,000
Q3 2020 Nov 12, 2020	SELL	$8.49 - $19.54 $23,050 - $53,051	-2,715 Reduced 9.55%	25,725 $218,000
Q2 2020 Aug 13, 2020	SELL	$7.44 - $11.29 $14,225 - $21,586	-1,912 Reduced 6.3%	28,440 $296,000
Q1 2020 May 06, 2020	BUY	$6.94 - $14.22 $5,586 - $11,447	805 Added 2.72%	30,352 $284,000
Q4 2019 Feb 05, 2020	BUY	$7.99 - $37.6 $3,092 - $14,551	387 Added 1.33%	29,547 $237,000
Q3 2019 Oct 23, 2019	BUY	$19.17 - $27.4 $11,847 - $16,933	618 Added 2.17%	29,160 $599,000
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $67,276 - $125,692	2,934 Added 11.46%	28,542 $745,000
Q1 2019 May 01, 2019	BUY	$32.69 - $47.91 $92,774 - $135,968	2,838 Added 12.46%	25,608 $995,000
Q4 2018 Jan 31, 2019	BUY	$37.1 - $50.11 $286,894 - $387,500	7,733 Added 51.43%	22,770 $957,000
Q3 2018 Nov 07, 2018	SELL	$36.35 - $55.2 $39,221 - $59,560	-1,079 Reduced 6.7%	15,037 $752,000
Q2 2018 Aug 06, 2018	BUY	$33.85 - $50.65 $181,943 - $272,243	5,375 Added 50.04%	16,116 $616,000
Q1 2018 May 02, 2018	BUY	$32.45 - $54.7 $9,086 - $15,316	280 Added 2.68%	10,741 $431,000
Q4 2017 Feb 09, 2018	SELL	$21.8 - $39.35 $48,308 - $87,199	-2,216 Reduced 17.48%	10,461 $367,000
Q3 2017 Nov 06, 2017	BUY	$16.4 - $25.05 $207,902 - $317,558	12,677	12,677 $276,000

Others Institutions Holding WVE

# of Institutions

147

Shares Held

94M

Call Options Held

33K

Put Options Held

57.2K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.23B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Wave Life Sciences Ltd. Transaction History